EBITDA
8 mins read
Bayer Q3 sales show clear growth and proven earnings
Bayer Q3 sales exceeded expectations, with a positive outlook for 2026 earnings and cash flow.
Exagen Q2FY26 Results: What Makes This Revenue Record Worth Celebrating?
Exagen Q2FY26 Results show record revenue of $19.9 million, nearing EBITDA breakeven. What does this mean for investors?
